High Blood Pressure (Hypertension): Pathophysiology, Risk Factors, Symptoms, Diagnosis, and Evidence-Based Management

High blood pressure, medically termed hypertension, is a chronic elevation of systemic arterial pressure that progressively damages blood vessels, the heart, brain, kidneys, and eyes. Clinically, it is diagnosed when average blood pressure readings are persistently at or above 130/80 mmHg in most guidelines, typically confirmed across multiple occasions or with ambulatory/home monitoring to reduce variability. Hypertension is often asymptomatic for years, which is why it is frequently called a “silent” disease.

Mechanistically, hypertension results from a complex interaction between increased systemic vascular resistance, altered renal sodium handling, endothelial dysfunction, sympathetic nervous system activation, vascular remodeling, and hormonal regulation. In many adults, essential (primary) hypertension predominates and reflects polygenic susceptibility combined with environmental exposures such as high dietary sodium, low potassium intake, physical inactivity, excess adiposity, chronic stress, and disrupted sleep. These factors converge on pathways involving the renin-angiotensin-aldosterone system (RAAS), oxidative stress, and impaired nitric oxide–mediated vasodilation. Over time, smooth muscle hypertrophy and arterial stiffness increase, making blood pressure harder to control and raising the risk of cardiovascular events.

Risk stratification is central to hypertension care. Major contributors include age, family history, obesity, diabetes mellitus, chronic kidney disease, dyslipidemia, smoking, excessive alcohol consumption, and high-sodium dietary patterns. Sleep-disordered breathing, particularly obstructive sleep apnea, is a common and underrecognized driver through intermittent hypoxia and sympathetic surges. Certain medications and substances also elevate blood pressure, including nonsteroidal anti-inflammatory drugs (NSAIDs), corticosteroids, decongestants, stimulants, and some herbal supplements. Secondary hypertension should be considered when onset is young, control is difficult, or there are suggestive features such as hypokalemia (possible hyperaldosteronism), renal abnormalities (renal artery stenosis or parenchymal disease), or paroxysmal symptoms (pheochromocytoma).

Symptoms are typically absent until complications develop, though some people report headaches, dizziness, or epistaxis. Importantly, symptoms are not reliable markers of blood pressure severity; a “high” reading without symptoms still confers vascular risk. Acute severe hypertension (often defined as ≥180/120 mmHg) requires urgent assessment. If accompanied by signs of target-organ injury—such as chest pain, neurologic deficits, dyspnea, visual changes, confusion, or markedly elevated creatinine—this may represent a hypertensive emergency and demands rapid but carefully titrated blood pressure reduction in a monitored setting to avoid ischemia.

Diagnosis relies on accurate measurement technique: proper cuff size, seated rest, arm at heart level, avoidance of caffeine/nicotine/exercise shortly before measurement, and repeated readings. Confirmation may use ambulatory blood pressure monitoring (ABPM) or home blood pressure monitoring (HBPM) to distinguish sustained hypertension from “white-coat” hypertension, where clinic readings are high but out-of-office averages are normal. Laboratory evaluation commonly includes kidney function (serum creatinine/eGFR), electrolytes, fasting glucose or HbA1c, lipid profile, urinalysis, and assessment for end-organ effects. Additional tests may include ECG for left ventricular hypertrophy and echocardiography, depending on baseline risk and clinical findings.

Treatment is both lifestyle and pharmacologic. Core lifestyle interventions include dietary sodium reduction (with emphasis on processed foods), increased intake of fruits and vegetables and potassium-rich foods when appropriate, weight loss, regular aerobic activity, moderation of alcohol, smoking cessation, and improvement of sleep quality. Evidence-based dietary patterns such as the DASH (Dietary Approaches to Stop Hypertension) plan reduce blood pressure and improve vascular risk. Pharmacotherapy typically follows patient-specific factors and comorbidities. First-line classes often include thiazide-like diuretics, ACE inhibitors, ARBs, and calcium channel blockers; combination therapy is frequently required because hypertension is multifactorial. In selected patients, additional agents may be used, such as mineralocorticoid receptor antagonists, beta-blockers, or other vasodilators, while monitoring electrolytes, kidney function, heart rate, and adherence.

Long-term control substantially reduces morbidity and mortality, including stroke, myocardial infarction, heart failure, chronic kidney disease progression, and vascular dementia. Patient adherence is strongly influenced by regimen simplicity, side-effect management, and self-monitoring. Clinicians also address barriers such as medication costs, health literacy, and competing priorities. Because hypertension is chronic, structured follow-up and goal-directed titration are essential.

In the context of everyday life, stress and behavioral factors can temporarily raise blood pressure via sympathetic activation, but persistent hypertension requires sustained evaluation and management. If someone notices repeated elevated readings—especially if they are accompanied by concerning symptoms or reach severe ranges—they should seek medical assessment promptly rather than relying on transient explanations.

Source: [@StealthSteppin]